共 183 条
[1]
Yao JC(2008)One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States J. Clin. Oncol. 26 3063-3072
[2]
Modlin IM(2008)Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors J. Natl Cancer Inst. 100 1282-1289
[3]
Moss SF(2011)Everolimus for advanced pancreatic neuroendocrine tumors N. Engl. J. Med. 364 514-523
[4]
Chung DC(2009)Sunitinib paves the way for targeted therapies in neuroendocrine tumors Target. Oncol. 4 253-254
[5]
Jensen RT(1989)Synaptophysin and chromogranins/secretogranins—widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 58 95-121
[6]
Snyderwine E(1988)Identification of gastroenteropancreatic neuroendocrine cells in normal and neoplastic human tissue with antibodies against synaptophysin, chromogranin A, secretogranin I (chromogranin B), and secretogranin II Gastroenterology 95 1364-1374
[7]
Yao JC(2009)Review: the role of neural crest cells in the endocrine system Endocr. Pathol. 20 92-100
[8]
Raymond E(2004)Minireview: Development and differentiation of gut endocrine cells Endocrinology 145 2639-2644
[9]
Faivre S(2007)Survival from malignant digestive endocrine tumors in England and Wales: a population-based study Gastroenterology 132 899-904
[10]
Hammel P(1971)Pathologic analysis of carcinoids. Histologic reevaluation of 62 cases Cancer 28 990-998